Skip to main content

LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA

Position in NVAX — Novavax Inc

CIK 932974 BOSTON, MA

Position in NVAX

as of Jun 30, 2026 · filed Jul 30, 2026
Position Value
$5,369
+$730 QoQ
Shares Held
570
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#207
of 263 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NVAX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA holds $43,678,237 across 12 Biotechnology names. NVAX ranks #10 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NVAX

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,369 570
2026-03-31 $4,639 570
2025-12-31 $3,830 570
2025-09-30 $4,941 570
2025-06-30 $3,591 570
2025-03-31 $3,653 570
2024-12-31 $4,582 570
2024-09-30 $7,199 570
2024-06-30 $7,216 570
2024-03-31 $2,724 570
2023-12-31 $2,736 570
2023-09-30 $4,126 570
2023-06-30 $8,470 1,140